OraSure Technologies, Inc. (OSUR)
USD 2.93
(-2.66%)
USD 2.93
(-2.66%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 11.38 Million USD | 18.58% |
| 2022 | 9.6 Million USD | 4.92% |
| 2021 | 9.15 Million USD | 104.06% |
| 2020 | 4.48 Million USD | -19.58% |
| 2019 | 5.57 Million USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | -100.0% |
| 2009 | 7.79 Million USD | -6.14% |
| 2008 | 8.3 Million USD | -5.85% |
| 2007 | 8.81 Million USD | -12.09% |
| 2006 | 10.03 Million USD | 1034.65% |
| 2005 | 884.02 Thousand USD | -33.74% |
| 2004 | 1.33 Million USD | -45.68% |
| 2003 | 2.45 Million USD | -27.95% |
| 2002 | 3.4 Million USD | -4.94% |
| 2001 | 3.58 Million USD | -22.77% |
| 2000 | 4.64 Million USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | -100.0% |
| 1996 | 500 Thousand USD | -86.11% |
| 1995 | 3.6 Million USD | -12.2% |
| 1994 | 4.1 Million USD | -12.77% |
| 1993 | 4.7 Million USD | -14.55% |
| 1992 | 5.5 Million USD | 0.0% |
| 1991 | - USD | 0.0% |
| 1990 | - USD | 0.0% |
| 1989 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 10.5 Million USD | 0.0% |
| 2024 Q1 | 10.88 Million USD | 0.0% |
| 2023 Q2 | 12.44 Million USD | 36.88% |
| 2023 Q3 | 12 Million USD | -3.57% |
| 2023 Q4 | 11.38 Million USD | -5.14% |
| 2023 FY | 11.38 Million USD | 18.58% |
| 2023 Q1 | 9.09 Million USD | -5.3% |
| 2022 Q2 | 16.42 Million USD | 37.62% |
| 2022 Q3 | 15.42 Million USD | -6.06% |
| 2022 Q4 | 9.6 Million USD | -37.75% |
| 2022 Q1 | 11.93 Million USD | 30.37% |
| 2022 FY | 9.6 Million USD | 4.92% |
| 2021 FY | 9.15 Million USD | 104.06% |
| 2021 Q4 | 9.15 Million USD | -13.43% |
| 2021 Q3 | 10.57 Million USD | 7.43% |
| 2021 Q2 | 9.84 Million USD | 127.9% |
| 2021 Q1 | 4.31 Million USD | -3.72% |
| 2020 Q3 | 4.87 Million USD | -7.41% |
| 2020 Q2 | 5.26 Million USD | 1.6% |
| 2020 Q1 | 5.18 Million USD | -7.14% |
| 2020 FY | 4.48 Million USD | -19.58% |
| 2020 Q4 | 4.48 Million USD | -7.94% |
| 2019 FY | 5.57 Million USD | 0.0% |
| 2019 Q3 | 3.88 Million USD | -7.48% |
| 2019 Q4 | 5.57 Million USD | 43.69% |
| 2019 Q1 | 4.37 Million USD | 585.57% |
| 2019 Q2 | 4.19 Million USD | -4.09% |
| 2018 Q1 | - USD | 100.0% |
| 2018 FY | - USD | 0.0% |
| 2018 Q4 | -901 Thousand USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q1 | - USD | 100.0% |
| 2017 Q4 | -1.95 Million USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q4 | -2.44 Million USD | 0.0% |
| 2016 Q1 | - USD | 100.0% |
| 2016 FY | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q1 | - USD | 100.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q4 | -2.88 Million USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q4 | -3.23 Million USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q1 | - USD | 100.0% |
| 2012 Q4 | -4.4 Million USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q3 | - USD | 100.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q2 | -250 Million USD | 0.0% |
| 2010 Q1 | 7.66 Million USD | -1.6% |
| 2010 FY | - USD | -100.0% |
| 2010 Q4 | - USD | -100.0% |
| 2010 Q3 | 7.79 Billion USD | 0.0% |
| 2010 Q2 | - USD | -100.0% |
| 2009 Q3 | 7.91 Million USD | -1.55% |
| 2009 Q1 | 8.16 Million USD | -1.62% |
| 2009 FY | 7.79 Million USD | -6.14% |
| 2009 Q4 | 7.79 Million USD | -1.58% |
| 2009 Q2 | 8.04 Million USD | -1.53% |
| 2008 Q1 | 8.71 Million USD | -1.11% |
| 2008 FY | 8.3 Million USD | -5.85% |
| 2008 Q2 | 8.58 Million USD | -1.6% |
| 2008 Q3 | 8.44 Million USD | -1.63% |
| 2008 Q4 | 8.3 Million USD | -1.65% |
| 2007 Q4 | 8.81 Million USD | -5.51% |
| 2007 FY | 8.81 Million USD | -12.09% |
| 2007 Q2 | 9.98 Million USD | -0.23% |
| 2007 Q1 | 10 Million USD | -0.23% |
| 2007 Q3 | 9.33 Million USD | -6.54% |
| 2006 FY | 10.03 Million USD | 1034.65% |
| 2006 Q3 | 10.3 Million USD | -0.21% |
| 2006 Q1 | 850.68 Thousand USD | -3.77% |
| 2006 Q2 | 10.32 Million USD | 1113.71% |
| 2006 Q4 | 10.03 Million USD | -2.64% |
| 2005 Q1 | 1.05 Million USD | -20.79% |
| 2005 FY | 884.02 Thousand USD | -33.74% |
| 2005 Q4 | 884.02 Thousand USD | -5.23% |
| 2005 Q3 | 932.85 Thousand USD | -6.03% |
| 2005 Q2 | 992.73 Thousand USD | -6.07% |
| 2004 FY | 1.33 Million USD | -45.68% |
| 2004 Q1 | 2.17 Million USD | -11.59% |
| 2004 Q3 | 1.61 Million USD | -14.66% |
| 2004 Q4 | 1.33 Million USD | -17.24% |
| 2004 Q2 | 1.88 Million USD | -13.02% |
| 2003 Q1 | 3.21 Million USD | -5.7% |
| 2003 Q3 | 2.73 Million USD | -8.94% |
| 2003 FY | 2.45 Million USD | -27.95% |
| 2003 Q2 | 3 Million USD | -6.45% |
| 2003 Q4 | 2.45 Million USD | -10.31% |
| 2002 Q3 | 3.47 Million USD | 10.7% |
| 2002 Q4 | 3.4 Million USD | -2.01% |
| 2002 Q1 | 3.36 Million USD | -6.19% |
| 2002 Q2 | 3.14 Million USD | -6.58% |
| 2002 FY | 3.4 Million USD | -4.94% |
| 2001 Q1 | 4.34 Million USD | -6.38% |
| 2001 Q2 | 4.06 Million USD | -6.41% |
| 2001 Q3 | 3.82 Million USD | -5.87% |
| 2001 Q4 | 3.58 Million USD | -6.36% |
| 2001 FY | 3.58 Million USD | -22.77% |
| 2000 Q2 | - USD | 0.0% |
| 2000 FY | 4.64 Million USD | 0.0% |
| 2000 Q4 | 4.64 Million USD | -7.79% |
| 2000 Q1 | - USD | 0.0% |
| 2000 Q3 | 5.03 Million USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1999 Q2 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1998 Q4 | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1997 FY | - USD | -100.0% |
| 1997 Q1 | - USD | -100.0% |
| 1997 Q2 | - USD | 0.0% |
| 1997 Q4 | - USD | 0.0% |
| 1996 Q4 | 400 Thousand USD | -20.0% |
| 1996 Q1 | 3.6 Million USD | 0.0% |
| 1996 Q2 | 3.6 Million USD | 0.0% |
| 1996 Q3 | 500 Thousand USD | -86.11% |
| 1996 FY | 500 Thousand USD | -86.11% |
| 1995 Q1 | 3.6 Million USD | -12.2% |
| 1995 Q2 | 3.6 Million USD | 0.0% |
| 1995 Q3 | 3.6 Million USD | 0.0% |
| 1995 Q4 | 3.6 Million USD | 0.0% |
| 1995 FY | 3.6 Million USD | -12.2% |
| 1994 FY | 4.1 Million USD | -12.77% |
| 1994 Q4 | 4.1 Million USD | 0.0% |
| 1994 Q3 | 4.1 Million USD | 0.0% |
| 1994 Q2 | - USD | -100.0% |
| 1994 Q1 | 4.3 Million USD | -2.27% |
| 1993 FY | 4.7 Million USD | -14.55% |
| 1993 Q1 | 4.8 Million USD | 0.0% |
| 1993 Q2 | 4.7 Million USD | -2.08% |
| 1993 Q3 | 4.7 Million USD | 0.0% |
| 1993 Q4 | 4.4 Million USD | -6.38% |
| 1992 Q2 | - USD | 0.0% |
| 1992 Q1 | - USD | 0.0% |
| 1992 FY | 5.5 Million USD | 0.0% |
| 1992 Q3 | 5.5 Million USD | 0.0% |
| 1992 Q4 | 4.8 Million USD | -12.73% |
| 1991 Q3 | - USD | 0.0% |
| 1991 Q2 | - USD | 0.0% |
| 1991 Q1 | - USD | 0.0% |
| 1991 FY | - USD | 0.0% |
| 1991 Q4 | - USD | 0.0% |
| 1990 Q2 | - USD | 0.0% |
| 1990 FY | - USD | 0.0% |
| 1990 Q3 | - USD | 0.0% |
| 1990 Q1 | - USD | 0.0% |
| 1990 Q4 | - USD | 0.0% |
| 1989 FY | - USD | 0.0% |
| 1989 Q4 | - USD | 0.0% |
| 1989 Q2 | 100 Thousand USD | 0.0% |
| 1989 Q3 | - USD | -100.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 75.25 Million USD | 84.867% |
| AngioDynamics, Inc. | 3.93 Million USD | -189.109% |
| AtriCure, Inc. | 60.59 Million USD | 81.206% |
| Avinger, Inc. | - USD | -Infinity% |
| Azenta, Inc. | 60.43 Million USD | 81.157% |
| BioLife Solutions, Inc. | 18.31 Million USD | 37.808% |
| The Cooper Companies, Inc. | 2.52 Billion USD | 99.549% |
| Daxor Corporation | 755.65 Thousand USD | -1407.029% |
| Ekso Bionics Holdings, Inc. | 4.83 Million USD | -135.679% |
| Femasys Inc. | 4.25 Million USD | -167.438% |
| GlucoTrack, Inc. | 196 Thousand USD | -5710.204% |
| Harvard Bioscience, Inc. | 30.7 Million USD | 62.91% |
| Hologic, Inc. | 2.49 Billion USD | 99.544% |
| ICU Medical, Inc. | 1.57 Billion USD | 99.278% |
| Intuitive Surgical, Inc. | -82.1 Million USD | 113.871% |
| KORU Medical Systems, Inc. | 3.65 Million USD | -211.75% |
| LeMaitre Vascular, Inc. | 16.62 Million USD | 31.497% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Masimo Corporation | 871.7 Million USD | 98.694% |
| Microbot Medical Inc. | 40 Thousand USD | -28370.0% |
| Meihua International Medical Technologies Co., Ltd. | 4592.00 USD | -247896.516% |
| Merit Medical Systems, Inc. | 823.01 Million USD | 98.616% |
| Nephros, Inc. | 1.39 Million USD | -719.281% |
| NovoCure Limited | 596.24 Million USD | 98.09% |
| NEXGEL, Inc. | 513 Thousand USD | -2119.883% |
| NEXGEL, Inc. | 513 Thousand USD | -2119.883% |
| Singular Genomics Systems, Inc. | 67.52 Million USD | 83.135% |
| Pro-Dex, Inc. | 7.53 Million USD | -51.115% |
| Pulse Biosciences, Inc. | 8.08 Million USD | -40.836% |
| Predictive Oncology Inc. | 2.18 Million USD | -420.243% |
| Precision Optics Corporation, Inc. | 1.93 Million USD | -487.625% |
| QuidelOrtho Corporation | 2.27 Billion USD | 99.499% |
| Repligen Corporation | 510.14 Million USD | 97.768% |
| Sanara MedTech Inc. | 9.11 Million USD | -24.963% |
| STAAR Surgical Company | 31.46 Million USD | 63.81% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 295 Thousand USD | -3760.339% |
| DENTSPLY SIRONA Inc. | 1.79 Billion USD | 99.366% |
| Jin Medical International Ltd. | - USD | -Infinity% |